Multicystic peritoneal mesothelioma: Outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

European Journal of Surgical Oncology

Volumn 36, Issue 11, 2010, Pages 1047-1053

  Baratti, D ^a   Vaira, M ^b   Kusamura, S ^a   D'Amico, S ^b   Balestra, M R ^a   Cioppa, T ^b   Mingrone, E ^a   De Simone, M ^b   Deraco, M ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b San Giuseppe Hospital   (Italy)

Author keywords

Cytoreductive surgery; HIPEC; Hyperthermic intraperitoneal chemotherapy; Multicystic peritoneal mesothelioma; Peritonectomy

Indexed keywords

BIOLOGICAL MARKER; CARBOPLATIN; CISPLATIN; DOXORUBICIN; GEMCITABINE; KI 67 ANTIGEN; MITOMYCIN C; ANTINEOPLASTIC AGENT;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOREDUCTIVE SURGERY; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; MALE; MULTICYSTIC PERITONEAL MESOTHELIOMA; PERITONEUM MESOTHELIOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; CLINICAL TRIAL; INFUSION; KAPLAN MEIER METHOD; LENGTH OF STAY; MESOTHELIOMA; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MULTICENTER STUDY; PATHOLOGY; PATIENT SELECTION; PERITONEAL NEOPLASMS; PROCEDURES; PROGNOSIS; REGIONAL PERFUSION; RETROSPECTIVE STUDY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; KAPLAN-MEIERS ESTIMATE; LENGTH OF STAY; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM, RESIDUAL; PATIENT SELECTION; PERITONEAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME; KAPLAN-MEIER ESTIMATE;

EID: 77957881282     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.08.130     Document Type: Article

References (30)

1. A.N. Husain, T.V. Colby, and N.G. Ordóñez Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group Arch Pathol Lab Med 133 2009 1317 1331
2. T.D. Yan, M. Deraco, and D. Baratti Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience J Clin Oncol 27 2009 6237 6242
3. Y. Katsube, K. Mukai, and S.G. Silverberg Cystic mesothelioma of the peritoneum: a report of five cases and review of the literature Cancer 50 1982 1615 1622
4. S.W. Weiss, and F.A. Tavassoli Multicystic mesothelioma. An analysis of pathologic findings and biologic behavior in 37 cases Am J Surg Pathol 12 1988 737 746
5. M.J. Ross, W.R. Welch, and R.E. Scully Multilocular peritoneal inclusion cysts (so-called cystic mesotheliomas) Cancer 64 1989 1336 1346
6. H. Sawh, A. Malpica, M.T. Deavers, J. Liu, and E.G. Silva Benign cystic mesothelioma of the peritoneum: a clinicopathological study of 17 cases and immunohistochemical analysis of estrogen and progesterone receptor status Hum Path 34 2003 369 374
7. A.M. Vallerie, J.P. Lerner, J.D. Wright, and L.V. Baxi Peritoneal inclusion cysts: a review Obstet Gynecol Surv 64 2009 321 334
8. R. Mennemeyer, and M. Smith Multicystic peritoneal mesothelioma: a case report with electron microscopy of a case mimicking intra-abdominal cystic hygroma (lymphangioma) Cancer 44 1979 629 698
9. S. González-Moreno, H. Yan, K.W. Alcorn, and P.H. Sugarbaker Malignant transformation of "benign" cystic mesothelioma of the peritoneum J Surg Oncol 79 2002 243 251
10. C. Engohan-Aloghe, V. Anaf, and J.C. Noël Lymph node involvement in multicystic peritoneal mesothelioma Int J Gynecol Pathol 28 2009 594 597
11. A.L. Feldman, S.K. Libutti, and J.F. Pingpank Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy J Clin Oncol 21 2003 4560 4567
12. T.D. Yan, E.A. Brun, C.A. Cerruto, N. Haveric, D. Chang, and P.H. Sugarbaker Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma Ann Surg Oncol 14 2007 41 49
13. D. Baratti, S. Kusamura, A.D. Cabras, B. Laterza, M.R. Balestra, and M. Deraco Lymph node metastases in diffuse malignant peritoneal mesothelioma Ann Surg Oncol 17 2010 45 53
14. K. Sethna, F. Mohamed, P. Marchettini, D. Elias, and P.H. Sugarbaker Peritoneal cystic mesothelioma: a case series Tumori 89 2003 31 35
15. D. Baratti, S. Kusamura, D. Nonaka, G.D. Oliva, B. Laterza, and M. Deraco Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC) Ann Surg Oncol 14 2007 2790 2797
16. G. Passot, E. Cotte, and C. Brigand Peritoneal mesothelioma: treatment with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy J Chir (Paris) 145 2008 447 453
17. H. Yano, B.J. Moran, T.D. Cecil, and E.M. Murphy Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma Eur J Surg Oncol 35 2009 980 985
18. M.M. Oken, R.H. Creech, and D.C. Tormey Toxicity and response criteria of the eastern cooperative oncology group Am J Clin Oncol 5 1982 649 655
19. P. Jaquet, and P.H. Sugarbaker Current methodologies for clinical assessment of patients with peritoneal carcinomatosis J Exp Clin Cancer Res 15 1996 49 58
20. P.H. Sugarbaker Peritonectomy procedures Ann Surg 221 1995 29 42
21. M. De Simone, R. Barone, and M. Vaira Semi-closed hyperthermic- antiblastic peritoneal perfusion (HAPP) in the treatment of peritoneal carcinosis J Surg Oncol 82 2003 138 140
22. C.R. Rossi, M. Foletto, and S. Mocellin Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study Cancer 94 2002 492 499
23. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Soc 53 1958 457 481
24. D. Baratti, S. Kusamura, and A. Sironi Multicystic peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC) In Vivo 22 2008 153 157
25. D. Costamagna, S. Scuderi, M. Vaira, R. Barone, and M. De Simone Trattamento del mesotelioma peritoneale mediante citoriduzione e chemioipertermia intraperitoneale (CIIP) Tumori 89 2003 40 42
26. T.C. Chua, T.D. Yan, A. Saxena, and D.L. Morris Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality Ann Surg 249 2009 900 907
27. P.H. Sugarbaker, T.D. Yan, L. Zappa, N. Haveric, and E. Brun Thin-walled cysts as a pathognomonic CT finding in cystic mesothelioma Tumori 94 2008 14 18
28. C.A. Cerruto, E.A. Brun, D. Chang, and P.H. Sugarbaker Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma Arch Pathol Lab Med 130 2006 1654 1661
29. N. Zaffaroni, A. Costa, and M. Pennati Survivin is highly expressed and promotes cell survival in malignant peritoneal mesothelioma Cell Oncol 29 2007 453 466
30. T.C. Chua, P. Yao, and J. Akther Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesothelioma Pathol Oncol Res 15 2009 671 678